NOVT Novanta Inc.

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

Date	Price Target	Rating	Analyst
5/11/2022		Mkt Perform → Outperform	William Blair

Novanta Inc.

Recent Analyst Ratings for Novanta Inc.

Novanta Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Johnson Robert Matthew converted options into 818 shares (SEC Form 4)

Co-Chief Operating Officer Ravetto Charles Guy Jr converted options into 9,421 shares and covered exercise/tax liability with 3,418 shares, increasing direct ownership by 84% to 13,162 units (SEC Form 4)

Chief Financial Officer Buckley Robert converted options into 5,425 shares and covered exercise/tax liability with 2,623 shares, increasing direct ownership by 3% to 91,034 units (SEC Form 4)

Chief Executive Officer Glastra Matthijs converted options into 10,851 shares and covered exercise/tax liability with 5,247 shares, increasing direct ownership by 25% to 28,187 units (SEC Form 4)

Co-Chief Operating Officer Ravetto Charles Guy Jr covered exercise/tax liability with 242 shares and converted options into 824 shares, increasing direct ownership by 9% to 7,159 units (SEC Form 4)

Chief Accounting Officer Burke John Joseph Ii converted options into 872 shares and covered exercise/tax liability with 277 shares, increasing direct ownership by 8% to 7,899 units (SEC Form 4)

Chief Executive Officer Glastra Matthijs was granted 5,414 shares and covered exercise/tax liability with 2,618 shares, increasing direct ownership by 14% to 22,583 units (SEC Form 4)

Chief Financial Officer Buckley Robert was granted 1,995 shares and covered exercise/tax liability with 913 shares, increasing direct ownership by 1% to 88,232 units (SEC Form 4)

SEC Form 4 filed by General Counsel Welsh Michele Davis

SEC Form 4 filed by Co-Chief Operating Officer Lesica John